Percheron Therapeutics Ltd
ASX:PER

Watchlist Manager
Percheron Therapeutics Ltd Logo
Percheron Therapeutics Ltd
ASX:PER
Watchlist
Price: 0.074 AUD Market Closed
Market Cap: 76.7m AUD
Have any thoughts about
Percheron Therapeutics Ltd?
Write Note

Relative Value

The Relative Value of one PER stock under the Base Case scenario is 0.067 AUD. Compared to the current market price of 0.074 AUD, Percheron Therapeutics Ltd is Overvalued by 9%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PER Relative Value
Base Case
0.067 AUD
Overvaluation 9%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
90
vs Industry
4
Median 3Y
385.3
Median 5Y
1 566.8
Industry
2.5
Forward
52.4
vs History
vs Industry
Median 3Y
-9.6
Median 5Y
-13.7
Industry
21.9
Forward
-2.8
vs History
vs Industry
Median 3Y
-10.4
Median 5Y
-15.8
Industry
16.5
vs History
vs Industry
Median 3Y
-10.3
Median 5Y
-15.5
Industry
23.6
vs History
47
vs Industry
18
Median 3Y
5.8
Median 5Y
8.5
Industry
2.1
vs History
87
vs Industry
4
Median 3Y
303.3
Median 5Y
1 523
Industry
2.6
Forward
44.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.2
vs History
vs Industry
Median 3Y
-7.6
Median 5Y
-11.4
Industry
13.3
Forward
-2.8
vs History
vs Industry
Median 3Y
-7.6
Median 5Y
-11.4
Industry
16.6
Forward
-2.8
vs History
vs Industry
Median 3Y
-8.5
Median 5Y
-13.4
Industry
15.6
vs History
vs Industry
Median 3Y
-8.4
Median 5Y
-13.4
Industry
19.1
vs History
vs Industry
4
Median 3Y
30.6
Median 5Y
109.9
Industry
1.9

Multiples Across Competitors

PER Competitors Multiples
Percheron Therapeutics Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Percheron Therapeutics Ltd
ASX:PER
76.7m AUD 124.7 -6.4 -4.5 -4.5
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
AU
Percheron Therapeutics Ltd
ASX:PER
Average P/E: 32.4
Negative Multiple: -6.4
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top